8
Oct
2024
KBI Biopharma
Exhibitor at CPHI Milan 2024 stand 5B89, Contract Manufacturing and Services & stand 5F91, Contract Manufacturing and Services
About Us
Categories
-
US -
2015On CPHI since
-
1000 - 4999Employees
Company types
Primary activities
Contact info
-
-
-
4117 Emperor Boulevard, NC 27703, Durham, NORTH CAROLINA, United States
.jpg)
.jpg)
Event information
CPHI Milan 2024
-
08 Oct 2024 - 10 Oct 2024
-
Fiera Milano, Italy
-
Visit us at stand 5B89, Contract Manufacturing and Services
Products Featured at CPHI Milan 2024
-
Product Cell Line Development
KBI offers a full suite of CLD across both mammalian and microbial expression systems. KBI can apply established mammalian recombinant protein expression systems to provide rapid and industry-leading cell line generation services using: CHO-M Selexis SUREtechnology, CHO-ZN, CHO-DG44, CHO-S, and CHO-K1 GS. ... -
Product Process Development
The clinical and commercial success of biotherapeutics hinges on developing robust, reproducible, and scalable processes. KBI's extensive process development and analytical development capabilities help our partners generate active products at an attractive cost while enabling rapid, reliable transfer to c... -
Product Analytical Development
With top expertise in protein analytics, KBI has successfully completed over 3300 analytical projects for more than 300 customers and more than 130 distinct molecules.
Our experience includes antibodies (IgG1, IgG4, IgM, FAb, ADC, Fc fusion), enzymes, cytokines, growth factors, highly glycosylat... -
Product Formulation Development
KBI’s approach to formulation development is based on the strategic pairing of two complementary scientific disciplines:
• Establishing a comprehensive understanding of the thermal, physical, chemical, and conformational stability. • Employing statistical design-of-experiment (DOE) to evaluate main ef... -
Product Characterization
Scale-down process characterization studies performed using a qualified scale-down model are a critical part of licensure applications for biologics.
KBI has significant expertise in the design and execution of these studies to enable customers to define their process control strategy to take ... -
Product Clinical Manufacturing
KBI Biopharma offers a broad range of cGMP biologics manufacturing services to biopharmaceutical companies worldwide. Our capabilities include reliable manufacturing for preclinical and clinical supply.
KBI’s experienced team produces high-quality therapeutics and vaccines thro... -
Product cGMP Mammalian Production
KBI offers global cGMP Mammalian Production, and organizational highlights include: • First CDMO to implement 2,000L single-use cGMP operations • High throughput single-use technology (AKTA Ready XL, 2500L SUM, 12m2 TFF) • A broad range of cGMP biologics manufacturing services from pre-clinical thr... -
Product cGMP Microbial Production
The KBI Boulder facility has extensive experience in generating E. coli based expression systems for high-level expression of recombinant proteins, typically using T7 expression in the BL21(DE3) strain as a platform. Following demonstration of expression in shake flasks, fermentation development ... -
Product Commercial Mass Spectrometry Services
Mass spectrometry is among the most powerful analytical techniques available for protein characterization. KBI’s state-of-the-art mass spectrometry core facility delivers unparalleled structural characterization services to our clients.
Our expert team brings decades of experience in protein and p... -
Product Cell Therapy Services
KBI's Cell Therapy team, located in The Woodlands, TX, has managed a fully functional manufacturing facility supporting cell therapies and developing therapies under IND since 2001. Our team has substantial expertise and knowledge in cellular therapies' manufacturing, process development, and regulato... -
Product PUREplatform™
At KBI Biopharma, our PUREplatform is everything you need to make a protein. Containing plasmids, strains, media, and a fermentation process that all fit together into a service package catered to your needs.
• Features our PUREcoli™ cell line, our proprietary high-producing E. coli ce... -
Product SUREmAb™
Built on the SUREtechnology Platform, SUREmAb optimizes monoclonal antibody (mAb) development and manufacturing processes, fast-tracking the path to clinic and market. • Fast-tracked for efficiency and speed, taking you from DNA transfection to GMP drug substance in 11 months • Comprehensive mAb develop... -
Product SUREtechnology Platform™
With our advanced gene technology and proprietary cell line, we are able to overcome common bottlenecks that come with developing high-performance mammalian cell lines, especially when expressing novel molecule types.
Mammalian cells are the gold standard for biologics development.
... -
Product Biologic Drug Substance & Drug Product Formulation
To date, KBI has conducted over 130 successful protein, peptide, and vaccine formulation development programs. KBI's approach to formulation development is based on the strategic pairing of two complementary scientific disciplines: Establishing a comprehensive understanding of the thermal, physical, chemic... -
Product cGMP Protein and Antibody Purification
KBI Biopharma has extensive experience developing purification processes for a wide variety of biotherapeutics, including: -Monoclonal antibodies-Bispecific antibodies -Enzymes -Fc fusion proteins -PEGylated proteins -Complex glycoproteins KBI supports 40+ annual programs ranging from FIH (First-in-Huma...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance